Vincerx Pharma Reports Fourth Quarter and Full Year 2020 Financial Results and Provides a Corporate Update

NEXT STORY
Point-of-Care Data Management Software Market Forecast to 2027 – COVID-19 Impact and Global Analysis By Application ; End User, and Geography
PREV STORY
DIAMOND Mouse Model is Latest in a String of Nonclinical Studies Confirming the Antifibrotic Effects of Hepion Pharmaceutical’s Lead Drug, CRV431
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Zai Lab Limited Appoints Billy Cho as Chief Financial Officer

SHANGHAI, China, March 05, 2018 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ:ZLAB), a Shanghai-based ...

author_avatar
NASDAQ Market News

Exagen Diagnostics Closes Series F Equity and Debt Raise Totaling $48 Million

ALBERQUEQUE, NM and SAN DIEGO, CA, Sept. 11, 2017 (GLOBE NEWSWIRE) -- Exagen Diagnostics ...

author_avatar
NASDAQ Market News

Inovio Announces Treatment of First Patient in Immuno-Oncology Study for Glioblastoma (GBM) with INO-5401 in Combination with Regeneron’s PD-1 Inhibitor

Phase 1/2 clinical trial combines Regeneron’s PD-1 inhibitor cemiplimab and Inovio’s immunotherapy INO-5401 in ...

author_avatar
NASDAQ Market News